P2P review · TNF inhibitor
Infliximab (Remicade) P2P review prep
TNF inhibitor. Indications: RA, PsA, AS, Crohn's, UC, psoriasis
Drug class
TNF inhibitor
Payer criteria typically applied
- DMARD failure
- TB screen
- Infusion site
Common medical director objections
- Step therapy
- Biosimilar (Inflectra, Renflexis) required
Pitfalls to avoid
- Site of care for infusion
Frequently asked questions
What does the payer typically require for Infliximab (Remicade)?
DMARD failure; TB screen; Infusion site.
What objections does the medical director typically raise?
Step therapy; Biosimilar (Inflectra, Renflexis) required.
What pitfalls should I avoid during the P2P call?
Site of care for infusion.
Related class drugs
Sources
Prep Infliximab (Remicade) P2Ps faster — try ApprovalHelp free
ApprovalHelp auto-prepares P2P talking points from the patient's chart, surfaces payer-specific objections, and generates the post-call appeal draft. no setup fee.
Get started →Contact: hello@approvalhelp.com